Agmatine blocks acquisition and re-acquisition of intravenous morphine self-administration in rats

Pharmacology Biochemistry and Behavior

Volumn 92, Issue 4, 2009, Pages 676-682

  Su, Rui Bin ^a   Wang, Wei Ping ^b   Lu, Xin Qiang ^a   Wu, Ning ^a   Liu, Zhi min ^b   Li, Jin ^a  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Agmatine; Drug self administration; Morphine

Indexed keywords

AGMATINE; MORPHINE; SULBACTAM;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL INFECTION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; DRUG POTENCY; DRUG SELF ADMINISTRATION; INTRAVENOUS DRUG ABUSE; LONG TERM CARE; MALE; MORPHINE ADDICTION; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGMATINE; ANIMALS; DISEASE MODELS, ANIMAL; EXTINCTION, PSYCHOLOGICAL; INFUSIONS, INTRAVENOUS; MALE; MORPHINE; NARCOTICS; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION; SUBSTANCE-RELATED DISORDERS;

RATTUS;

EID: 67349217403     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.03.009     Document Type: Article

References (41)

1. Adams M.L., Sewing B.N., Chen J., Meyer E.R., and Cicero T.J. Nitric oxide-related agents alter alcohol withdrawal in male rats. Alcohol Clin Exp Res 19 (1995) 195-199
2. Ahmed S.H., and Koob G.F. Cocaine- but not food-seeking behavior is reinstated by stress after extinction. Psychopharmacology 132 (1997) 289-295
3. Ahmed S.H., and Koob G.F. Transition from moderate to excessive drug intake: change in hedonic set point. Science 282 (1998) 298-300
4. Aricioglu-Kartal F., and Uzbay I.T. Inhibitory effect of agmatine on naloxone-precipitated abstinence syndrome in morphine dependent rats. Life Sci 61 (1997) 1775-1781
5. Carter B.L., and Tiffany S.T. Meta-analysis of cue-reactivity in addiction research. Addiction 94 (1999) 327-340
6. De Vries T.J., and Shippenberg T.S. Neural systems underlying opiate addiction. J Neurosci 22 (2002) 3321-3325
7. de Wit H. Priming effects with drugs and other reinforcers. Exp Clin Psychopharmacol 4 (1996) 5-10
8. Fairbanks C.A., and Wilcox G.L. Acute tolerance to spinally administered morphine compares mechanistically with chronically induced morphine tolerance. J Pharmacol Exp Ther 282 (1997) 1408-1417
9. Fairbanks C.A., Schreiber K.L., Brewer K.L., Yu C.G., Stone L.S., Kitto K.F., et al. Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. Proc Natl Acad Sci U S A 97 (2000) 10584-10589
10. Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci 14 (1991) 60-67
11. Gibson D.A., Harris B.R., Rogers D.T., and Littleton J.M. Radioligand binging studies reveal agmatine is a more selective antagonist for a polyamine-site on the NMDA receptor than arcaine or ifenprodil. Brain Res 952 (2002) 71-77
12. Greenwald M.K., and Roehrs T.A. Mu-opioid self-administration vs passive administration in heroin abusers produces differential EEG activation. Neuropsychopharmacology 30 (2005) 212-221
13. Heidbreder C.A., and Hagan J.J. Novel pharmacotherapeutic approaches for the treatment of drug addiction and craving. Curr Opin Pharmacol 5 (2005) 107-118
14. Kolesnikov Y., Jain S., and Pasternak G.W. Modulation of opioid analgesia by agmatine. Eur J Pharmacol 296 (1996) 17-22
15. Kreek M.J., and Koob G.F. Drug dependence: stress and dysregulation of brain reward systems. Drug Alcohol Depend 51 (1998) 23-47
16. Li G., Regunathan S., Barrow C.J., Eshraghi J., Cooper R., and Reis D.J. Agmatine: an endogenous clonidine-displacing substance in the brain. Science 263 (1994) 966-969
17. Li J., Li X., Pei G., and Qin B.Y. Agmatine inhibited tolerance to and dependence on morphine in guinea pig ileum in vitro. Acta Pharmacol Sin 19 (1998) 564-568
18. Li J., Li X., Pei G., and Qin B.Y. Effect of agmatine on tolerance to and substance dependence on morphine in mice. Acta Pharmacol Sin 20 (1999) 232-238
19. Li J., Li X., Pei G., and Qin B.Y. Correlation between inhibitions of morphine withdrawal and nitric-oxide synthase by agmatine. Acta Pharmacol Sin 20 (1999) 375-380
20. Mendelson J.H., and Mello N.K. Management of cocaine abuse and dependence. N Engl J Med 334 (1996) 965-972
21. Morgan A.D., Campbell U.C., Fons R.D., and Carroll M.E. Effect of agmatine on the escalation of intravenous cocaine and fentanyl self-administration in rats. Pharmacol Biochem Behav 72 (2002) 873-880
22. Nestler E.J. Historical review: molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol Sci 25 (2004) 210-218
23. O'Brien C.P. A range of research-based pharmacotherapies for addiction. Science 278 (1997) 66-70
24. Popik P., Wrobel M., and Bisaga A. Reinstatement of morphine-conditioned reward is blocked by memantine. Neuropsychopharmacology 31 (2006) 160-170
25. Reis D.J., and Regunathan S. Is agmatine a novel neurotransmitter in brain?. Trends Pharmacol Sci 21 (2000) 187-193
26. Ruiz-Durantez E., Llorente J., Ulibarri I., Pineda J., and Ugedo L. Agmatine-morphine interaction on nociception in mice. Ann N Y Acad Sci 1009 (2003) 133-136
27. Shaham Y., Rajabi H., and Stewart J. Relapse to heroin-seeking in rats under opioid maintenance: the effects of stress, heroin priming, and withdrawal. J Neurosci 16 (1996) 1957-1963
28. Shalev U., Grimm J.W., and Shaham Y. Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev 54 (2002) 1-42
29. Su R.B., Li J., and Qin B.Y. A biphasic opioid function modulator: agmatine. Acta Pharmacol Sin 24 (2003) 631-636
30. Su R.B., Lu X.Q., Huang Y., Liu Y., Gong Z.H., Wei X.L., et al. Effects of intragastric agmatine on morphine-induced physiological dependence in beagle dogs and rhesus monkeys. Eur J Pharmacol 587 (2008) 155-162
31. Su R.B., Ren Y.H., Liu Y., Ding T., Lu X.Q., Wu N., et al. Agmatine inhibits morphine-induced drug discrimination in rats. Eur J Pharmacol 593 (2008) 62-67
32. Sugawara A.M., Miguel T.T., Pereira D.T., Menani J.V., and De Luca L.A. Effects of central imidazolinergic and alpha2-adrenergic activation on water intake. Braz J Med Biol Res 34 (2001) 1185-1190
33. Uzbay I.T., and Oglesby M.W. Nitric oxide and substance dependence. Neurosci Biobehav Rev 25 (2001) 43-52
34. Uzbay I.T., Erden B.F., Tapanyigit E.E., and Kayaalp S.O. Nitric oxide synthase inhibition attenuates signs of ethanol withdrawal in rats. Life Sci 61 (1997) 2197-2209
35. Uzbay I.T., Grewal J.S., Wallis C.J., Dungan L.F., and Lal H. Nitric oxide synthase inhibition attenuates saccharin or ethanol reinforced responding in Long-Evans rats. Prog Neuro-Psychopharmacol Biol Psychiatry 22 (1998) 1411-1423
36. Uzbay I.T., Yesilyurt O., Celik T., Ergun H., and Isimer A. Effect of agmatine on ethanol withdrawal syndrome in rats. Behav Brain Res 107 (2000) 153-159
37. Walker E.A., Picker M.J., Granger A., and Dykstra L.A. Effects of opioids in morphine-treated pigeons trained to discriminate among morphine, the low-efficacy agonist nalbuphine, and saline. J Pharmacol Exp Ther 310 (2004) 150-158
38. Wei X.L., Su R.B., Lu X.Q., Liu Y., Yu S.Z., Yuan B.L., et al. Inhibition by agmatine on morphine-induced conditioned place preference in rats. Eur J Pharmacol 515 (2005) 99-106
39. Wei X.L., Su R.B., Wu N., Lu X.Q., Zheng J.Q., and Li J. Agmatine inhibits morphine-induced locomotion sensitization and morphine-induced changes in striatal dopamine and metabolites in rats. Eur Neuropsychopharmacol 17 (2007) 790-799
40. Weng X.C., Gai X.D., Zheng J.Q., and Li J. Agmatine blocked voltage-gated calcium channel in cultured rat hippocampal neurons. Acta Pharmacol Sin 24 (2003) 746-750
41. Yeşilyurt O., and Uzbay I.T. Agmatine potentiates the analgesic effect of morphine by an alpha(2)-adrenoceptor-mediated mechanism in mice. Neuropsychopharmacology 25 (2001) 98-103